640 vs MX6A: Side-by-Side Comparison
Compare China Resources Pharmaceutical Group Limited (640) and GRAND PHARM. GRP. HD-01 (MX6A) side by side: market cap EUR 2.97B vs EUR 1.79B, P/E 5.9 vs 12.4. Financials, growth and model signals on Bullrun.
| Metric | 640 | MX6A |
|---|---|---|
| Company | China Resources Pharmaceutical Group Limited | GRAND PHARM. GRP. HD-01 |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 2.97B | EUR 1.79B |
| P/E ratio | 5.9 | 12.4 |
| Dividend yield | 5.14% | 3.68% |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 269.57B | EUR 11.64B |
| Revenue growth YoY | +4.6% | +10.6% |
| Net income | EUR 4.05B | EUR 2.47B |
| Gross margin | 16.5% | 57.9% |
| Diluted EPS | 0.64 | 0.70 |